SS Innovations Reports Record Q2 Revenue of $13.9M, Up 39.4%, as Surgical Robot Installations Surge

SS Innovations International's record Q2 2026 revenue and growing installation base for its SSi Mantra surgical robot highlight the company's expanding global footprint and progress toward regulatory approvals.

Phoenix Metrowire Staff
Healthcare
SS Innovations Reports Record Q2 Revenue of $13.9M, Up 39.4%, as Surgical Robot Installations Surge

SS Innovations International (NASDAQ: SSII) has announced record second-quarter 2026 revenue of $13.9 million, a 39.4% increase from $10 million in the same period last year. The company's surgical robotic system, SSi Mantra, saw installations rise 30.4% to 30 during the quarter, contributing to a cumulative installed base of 224 systems across 12 countries as of June 30.

The revenue growth was accompanied by a 20% rise in gross profit to $7.1 million, with a gross margin of 50.9%. However, the company reported a net loss of $2.7 million, or $0.01 per diluted share, compared to a net loss of $0.3 million in the prior year quarter. For the first half of 2026, revenue increased 65.6% to $25 million, with installations up 47.4% to 56 systems.

SS Innovations ended the quarter with $13.6 million in cash and cash equivalents and no long-term debt. The company also highlighted significant clinical milestones, including 12,272 cumulative procedures using the SSi Mantra, of which 175 were telesurgeries. Notably, the company completed a robotic telesurgery spanning more than 13,600 miles between Colombia and India, underscoring the system's remote capabilities.

Looking ahead, SS Innovations expects the U.S. Food and Drug Administration (FDA) to complete its review of the company's 510(k) premarket notification for the SSi Mantra by the end of the first quarter of 2027. The company also believes it can obtain European Union CE marking certification by the end of 2026. These regulatory approvals are crucial for expanding into key markets and could significantly boost adoption.

The strong financial performance and operational progress come as SS Innovations aims to make robotic surgery more affordable and accessible globally. With a growing installed base and a pipeline of regulatory approvals, the company is positioning itself to compete in the surgical robotics market, which is dominated by established players. The company's focus on telesurgery could also open new opportunities in remote and underserved regions.

Investors and industry analysts will be watching closely as SS Innovations navigates the regulatory landscape and scales its operations. The company's ability to maintain growth while managing costs will be key to its long-term success. For more details, visit https://ibn.fm/nTMso.

Blockchain Registration

QR Code for Blockchain Registration